TH1 TH2 CYTOKINE EXPRESSION IN SALIVA OF HIV-POSITIVE AND HIV-NEGATIVE INDIVIDUALS - A PILOT-STUDY IN HIV-POSITIVE INDIVIDUALS WITH OROPHARYNGEAL CANDIDIASIS/
Je. Leigh et al., TH1 TH2 CYTOKINE EXPRESSION IN SALIVA OF HIV-POSITIVE AND HIV-NEGATIVE INDIVIDUALS - A PILOT-STUDY IN HIV-POSITIVE INDIVIDUALS WITH OROPHARYNGEAL CANDIDIASIS/, Journal of acquired immune deficiency syndromes and human retrovirology, 19(4), 1998, pp. 373-380
Current data suggest that T-helper (Th)2-type cytokine responses are o
ften associated with progression to AIDS in HIV-positive individuals.
Similarly, Th2-type cytokines are associated with susceptibility to mu
cosal candidiasis, of which oropharyngeal candidiasis (OPC) is one of
the most common opportunistic infections in HIV-positive individuals.
Although little information is available on host defense mechanisms at
the level of the oral mucosa, recent studies suggest that local cell-
mediated immunity (CMI) is equally or more important than that in the
periphery for host defense against mucosal Candida albicans infections
. This study investigated the potential presence of oral-associated CM
I through the expression of Th1/Th2-type cytokines in saliva of immuno
competent and immunocompromised individuals with and without OPC. Resu
lts showed a constitutive mixed Th1/Th2 cytokine expression (Th0) in w
hole saliva of healthy HIV-negative individuals. In contrast, HIV-posi
tive individuals had a dominant Th2-type salivary cytokine profile (in
terleukin-4 [IL-4], IL-10) (IL-2, interferon-gamma [IFN-gamma], IL-12)
that seemingly resulted from a lack of Th1-type cytokines rather than
enhanced Th2-type cytokines. Moreover, pilot analyses of those with O
PC showed evidence for a more profound salivary Th2-type profile. Both
HIV-positive and HIV-negative patients, irrespective of CD4 counts, h
ad some level of positive in vitro systemic lymphocyte proliferative r
esponses to C albicans antigens, These results suggest that the Th1/Th
2 cytokine dichotomy in HIV disease is detectable in situ in oral secr
etions and may be a useful indicator of oral-associated CMI to better
understand resistance/susceptibility of HIV-positive individuals to or
al opportunistic infections, including OPC.